TNG Pharmaceuticals
Louisville · Founded 2011
About TNG Pharmaceuticals
TNG Pharmaceuticals, a Louisville, KY based company is focused on the research and development of our patented vaccine, FlyVax. TNG Pharmaceuticals began at the University of Louisville in the Entrepreneurship MBA program. TNG competed on a global business plan competition circuit: winning four of five competitions, including the world's largest, richest, and most prestigious competitions.
Company Facts
- Founded: 2011
- Legal name: TNG Pharmaceuticals, Inc.
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2014)
- Website: flyvax.com
- Phone: +1 888-345-0878
Social Profiles
Canonical: https://fsome.com/organization/tng-pharmaceuticals-8291566 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.